Andrew Vaillant

Depolarization and Neurotrophins Converge on the Phosphatidylinositol 3-Kinase–Akt Pathway to Synergistically Regulate Neuronal Survival

Andrew Vaillant, Irene Mazzoni, Christopher Tudan et al. · The Journal of Cell Biology · 1999 · 251 citations · Full text

Life Sciences, Neurobiology, Neuroscience +13

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 249 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Signaling Mechanisms Underlying Reversible, Activity-Dependent Dendrite Formation

Andrew Vaillant, Patrizia Zanassi, Gregory S. Walsh et al. · Neuron · 2002 · 242 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

Michel Bazinet, Victor Pântea, Gheorghe Plăcintă et al. · Gastroenterology · 2020 · 232 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection

Mamun Al‐Mahtab, Michel Bazinet, Andrew Vaillant · PLoS ONE · 2016 · 176 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15